107 related articles for article (PubMed ID: 8579102)
1. In vitro and in vivo stimulation of the murine immune system by AGM-1470, a potent angiogenesis inhibitor.
Antoine N; Daukandt M; Heinen E; Simar LJ; Castronovo V
Am J Pathol; 1996 Feb; 148(2):393-8. PubMed ID: 8579102
[TBL] [Abstract][Full Text] [Related]
2. Simulation of human B-lymphocyte proliferation by AGM-1470, a potent inhibitor of angiogenesis.
Antoine N; Bours V; Heinen E; Simar LJ; Castronovo V
J Natl Cancer Inst; 1995 Jan; 87(2):136-9. PubMed ID: 7535858
[No Abstract] [Full Text] [Related]
3. The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitro.
Schoof DD; Obando JA; Cusack JC; Goedegebuure PS; Brem H; Eberlein TJ
Int J Cancer; 1993 Oct; 55(4):630-5. PubMed ID: 7691763
[TBL] [Abstract][Full Text] [Related]
4. The potent angioinhibin AGM-1470 stimulates normal but not human tumoral lymphocytes.
Antoine N; Daukandt M; Locigno R; Heinen E; Simar LJ; Castronovo V
Tumori; 1996; 82(1):27-30. PubMed ID: 8623499
[TBL] [Abstract][Full Text] [Related]
5. AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle.
Antoine N; Greimers R; De Roanne C; Kusaka M; Heinen E; Simar LJ; Castronovo V
Cancer Res; 1994 Apr; 54(8):2073-6. PubMed ID: 7513609
[TBL] [Abstract][Full Text] [Related]
6. Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells.
McLeskey SW; Zhang L; Trock BJ; Kharbanda S; Liu Y; Gottardis MM; Lippman ME; Kern FG
Br J Cancer; 1996 May; 73(9):1053-62. PubMed ID: 8624263
[TBL] [Abstract][Full Text] [Related]
7. CpG oligodeoxynucleotide-induced immunity prevents growth of germinal center-derived B lymphoma cells.
Ponzio NM; Cutro S; Hu J; Marzouk A; Marshall JD
Int Immunopharmacol; 2006 Dec; 6(13-14):2057-68. PubMed ID: 17161362
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lymphatic metastasis in a syngeneic rat fibrosarcoma model by an angiogenesis inhibitor, AGM-1470.
Futami H; Iseki H; Egawa S; Koyama K; Yamaguchi K
Invasion Metastasis; 1996; 16(2):73-82. PubMed ID: 9030242
[TBL] [Abstract][Full Text] [Related]
9. Modulation of T lymphocyte function by the angiogenesis inhibitor AGM-1470.
Berger AE; Dortch KA; Staite ND; Mitchell MA; Evans BR; Holm MS
Agents Actions; 1993; 39 Spec No():C86-8. PubMed ID: 8273596
[TBL] [Abstract][Full Text] [Related]
10. Increased growth and incidence of lymph node metastases due to the angiogenesis inhibitor AGM-1470.
Hori K; Li HC; Saito S; Sato Y
Br J Cancer; 1997; 75(12):1730-4. PubMed ID: 9192974
[TBL] [Abstract][Full Text] [Related]
11. Analysis of experimental antiangiogenic therapy.
Brem H; Folkman J
J Pediatr Surg; 1993 Mar; 28(3):445-50; discussion 450-1. PubMed ID: 7682259
[TBL] [Abstract][Full Text] [Related]
12. Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice.
Funakoshi S; Taub DD; Anver MR; Raziuddin A; Asai O; Reddy V; Rager H; Fanslow WC; Longo DL; Murphy WJ
J Clin Invest; 1997 Feb; 99(3):484-91. PubMed ID: 9022082
[TBL] [Abstract][Full Text] [Related]
13. Primary study in experimental antiangiogenic therapy of nasopharyngeal carcinoma with AGM-1470 (TNP-470).
Qian CN; Min HQ; Lin HL; Hong MH; Ye YL
J Laryngol Otol; 1998 Sep; 112(9):849-53. PubMed ID: 9876375
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis in vivo by interleukin 12.
Voest EE; Kenyon BM; O'Reilly MS; Truitt G; D'Amato RJ; Folkman J
J Natl Cancer Inst; 1995 Apr; 87(8):581-6. PubMed ID: 7538593
[TBL] [Abstract][Full Text] [Related]
15. Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470).
Yamamoto T; Sudo K; Fujita T
Anticancer Res; 1994; 14(1A):1-3. PubMed ID: 7513139
[TBL] [Abstract][Full Text] [Related]
16. In vitro inhibition of endothelial cell growth by the antiangiogenic drug AGM-1470 (TNP-470) and the anti-endoglin antibody TEC-11.
Maier JA; Delia D; Thorpe PE; Gasparini G
Anticancer Drugs; 1997 Mar; 8(3):238-44. PubMed ID: 9095328
[TBL] [Abstract][Full Text] [Related]
17. AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo.
Takamiya Y; Brem H; Ojeifo J; Mineta T; Martuza RL
Neurosurgery; 1994 May; 34(5):869-75; discussion 875. PubMed ID: 8052385
[TBL] [Abstract][Full Text] [Related]
18. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent.
Kusaka M; Sudo K; Fujita T; Marui S; Itoh F; Ingber D; Folkman J
Biochem Biophys Res Commun; 1991 Feb; 174(3):1070-6. PubMed ID: 1705118
[TBL] [Abstract][Full Text] [Related]
19. Selective modulation of B-cell activation markers CD86 and I-Ak on murine draining lymph node cells following allergen or irritant treatment.
Gerberick GF; Cruse LW; Miller CM; Ridder GM
Toxicol Appl Pharmacol; 1999 Sep; 159(2):142-51. PubMed ID: 10495778
[TBL] [Abstract][Full Text] [Related]
20. The angiogenesis inhibitor AGM-1470 selectively increases E-selectin.
Budson AE; Ko L; Brasel C; Bischoff J
Biochem Biophys Res Commun; 1996 Aug; 225(1):141-5. PubMed ID: 8769107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
